Detalles de la búsqueda
1.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Front Oncol
; 12: 934638, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837107
2.
Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
Clin Breast Cancer
; 6(5): 446-54, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16381629
3.
A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
Oncologist
; 9(6): 696-707, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15561813
Resultados
1 -
3
de 3
1
Próxima >
>>